| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5699752 | Clinical Oncology | 2006 | 6 Pages |
Abstract
These results suggest that S-1 plus low-dose cisplatin against gastric cancer may contribute to long survival when it induces moderate neutropenia.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
B. Nakata, A. Tsuji, Y. Mitachi, S. Yamamitsu, K. Hirata, T. Takeuchi, T. Shirasaka, K. Hirakawa,